The Role of Health Economics and Outcomes Research in Addressing Coronavirus Disease 2019 (COVID-19)


While the world awaits new treatments and vaccines for coronavirus disease 2019 (COVID-19), the health economics and outcomes research (HEOR) community is already examining various aspects of the novel coronavirus severe acute respiratory syndrome coronavirus 2 of the genus Betacoronavirus (SARS-CoV-2) pandemic. At this point, the emerging literature mainly considers the cost of the pandemic and health economic issues surrounding the development of policies. Some modeling work is being conducted to determine the potential value of future treatments or vaccines, and those models will no doubt be tailored and used to assess new health technologies as effectiveness data emerge.

We are pleased to present in the current issue a themed section of the first 6 articles that have been accepted to date. We are grateful to Jagpreet Chhatwal and Maarten Postma, who have served as associate editors for the majority of articles Value in Health has received.


C. Daniel Mullins Michael F. Drummond

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on Update my browser now